1742-4690-6-S2-P53 1742-4690 Poster presentation <p>The envelope of human endogenous retrovirus in neuro-inflammation</p> Dougier Hei-Lanne Lomparski Christina Villiers Christian Duperray Alain Bernard Corinne Jouvin-Marche Evelyne Perron Hervé Marche N Patrice

Université J Fourier, Inserm U823, Institut Albert Bonniot, Grenoble, 3800, France

Geneuro SA, Plan les Ouates, 1228, Switzerland

Retrovirology <p>Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts</p> Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1742-4690-6-S2-info.pdf <p>Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts</p> Montpellier, France 21-23 September 2009 http://www.frontiersofretrovirology.com 1742-4690 2009 6 Suppl 2 P53 http://www.retrovirology.com/content/6/S2/P53 10.1186/1742-4690-6-S2-P53
24 9 2009 2009 Dougier et al; licensee BioMed Central Ltd.

Several viruses are known to interact with the host defences either to escape from the immune responses or to gain advantage of inflammatory mediators to survive. Human endogenous retroviruses (HERV) are integrated and are estimated represent up to 8% o the human genome. An exogenous virus from HERV. W family was initially isolated from brain cells of patients suffering of multiple sclerosis and named MSRV 1. Several lines of evidence support that its envelope protein (ENV) or its soluble extra-cellular subunit (ENV-SU) contributes to inflammation associated with the disease: 1) ENV promotes polyclonal expansion of T lymphocytes 2, 2) ENV-SU induces human monocytes and dendritic cells (DC) to produce inflammatory cytokines through engagement of CD14 and TLR4 3.

In order to study in vivo effects of MSRV, mice were treated for experimental allergic encephalitis (EAE) induction, a mouse model for MS, after antigenic myelin peptide immunisation either with complete Freund's adjuvant or ENV-SU. Clinical score showed significant EAE symptoms in both mice but no symptoms in control mice receiving no adjuvant or no ENV (Fig. 1). Cultures of splenocytes from either ENV-SU or adjuvant treated mice, recalled with the myelin antigen, led to IFN-γ production (not shown), indicating T lymphocyte reactivity towards the myelin antigen.

To characterise the mode of action of ENV in mice, DC were cultured from C57BL/6 bone marrow and incubated with ENV-SU. DC secreted amounts of IL-6 (Fig. 2) and IL-12p70 (not shown) dose-dependant of the ENV-SU. Flow cytometry analysis for CMH-II, CD11c, B7.1 and B7.2 molecules DC demonstrated that DC were activated and underwent further differentiation upon ENV-SU exposure comparable to other known stimulations. DC derived from TLR4 (not shown) or CD14 deficient mice (Fig. 3) were unable to respond to ENV-SU stimulation, arguing that, as found in humans, TLR4/CD14 pathway is involved in DC responses in mice.

<p>Figure 1</p>

Clinical score follow-up of C57BL/6 mice injected with MOG 35-55 and IFA, CFA or ENV

Clinical score follow-up of C57BL/6 mice injected with MOG 35-55 and IFA, CFA or ENV. Mean values were calculated for each group of mice.

<p>Figure 2</p>

Activation of mouse dendritic cells by the envelope

Activation of mouse dendritic cells by the envelope. Bone marrow derived DC were incubated with either 0.5μg/ml or 1μg/ml of ENV-SU for 24 h and IL-6 was measured by ELISA. Before incubation with the cells, ENV-SU is incubated, or not, with the anti-ENV antibodies during 1 h at 4°C. Control samples are incubated with ENV-SU alone, with LPS or without stimulation (NA).

<p>Figure 3</p>

Activation of mouse dendritic cells by the envelope depends on CD14

Activation of mouse dendritic cells by the envelope depends on CD14. (see legend Fig2). CD14° = CD14 deficient mouse.

Conclusion

by promoting inflammatory response through CD14/TLR4 pathway, the envelope of MSRV/HERV contributes to EAE in mice and thus may be one of the key actors of MS etiology in humans.

<p>Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis</p> Perron H Garson JA Bedin F Beseme F Paranhos-Baccala G Komurian-Pradel F Mallet F Tuke PW Voisset C Blond JL Proc Natl Acad Sci USA 1997 94 7583 7588 23865 9207135 10.1073/pnas.94.14.7583 <p>Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation</p> Perron H Jouvin-Marche E Michel M Ounanian-Paraz A Camelo S Dumon A Jolivet-Reynaud C Marcel F Souillet Y Borel E Virology 2001 287 321 332 10.1006/viro.2001.1045 11531410 <p>The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses</p> Rolland A Jouvin-Marche E Viret C Faure M Perron H Marche PN J Immunol 2006 176 7636 7644 16751411